Advances in near-infrared responsive functional nanocomposites for bioimaging and antitumor researchShow others and affiliations
2025 (English)In: Journal of Controlled Release, ISSN 0168-3659, E-ISSN 1873-4995, Vol. 384, article id 113904Article, review/survey (Refereed) Published
Abstract [en]
Malignant tumors endanger human health, and their characteristics make treatment difficult. Near-infrared (NIR) light has become an ideal choice for biotherapy because it offers good penetrability and low damage. In recent years, NIR-based photothermal therapy, photodynamic therapy, photochemotherapy, and multimodal combination therapy have been developing rapidly, and the corresponding functional nanomaterials have been emerging. This review summarizes advances in NIR-triggered functional nanomaterials in tumor therapy, involving therapeutic reagent applications and synergistic and combined therapeutic systems. The nanomaterials have obvious advantages, such as the excellent performance of photothermal therapy- and photodynamic therapy-related nanomaterials, and multifunctional nanoplatforms capable of integrating multiple therapies. However, they face many challenges, such as the limitations of individual therapies and technical difficulties in the combined applications. In the future, we should focus on optimizing the materials, evaluating the combined therapeutic mechanism, innovating the technology and promoting clinical translation. The nanomaterials are expected to become the key means of clinical oncology treatment, bringing hope to overcome the malignant tumors.
Place, publisher, year, edition, pages
Elsevier BV , 2025. Vol. 384, article id 113904
Keywords [en]
Bioimaging, Biomolecule delivery, Functional nanomaterials, Multi-mode combination therapy, NIR, PDT agents, PTT agents, Theranostics
National Category
Pharmacology and Toxicology Nanotechnology for/in Life Science and Medicine
Identifiers
URN: urn:nbn:se:kth:diva-368514DOI: 10.1016/j.jconrel.2025.113904ISI: 001512643200002PubMedID: 40499761Scopus ID: 2-s2.0-105007978583OAI: oai:DiVA.org:kth-368514DiVA, id: diva2:1989774
Note
QC 20250818
2025-08-182025-08-182025-09-26Bibliographically approved